A biomimetic sensor surface to detect anti-β2-glycoprotein-I antibodies as a marker for antiphospholipid syndrome

A biomimetic sensor has been developed, that allows for quantification of autoantibodies related to the antiphospholipid syndrome (APS). Autoantibodies directed against the β2-glycoprotein-I (β2GP-I) are known as the best markers for diagnosis of APS, however, detection of such antibodies is still a challenge. The epitopes of β2GP-I are exposed upon binding to negatively charged membranes. The surface of the sensor chips was therefore modified with such type of membranes, on which β2GP-I molecules were subsequently immobilized as recognition elements. Using the label-free method, reflectometric interference spectroscopy, it was possible to quantify anti-β2GP-I antibodies and to calibrate the sensor chip in buffer. A mild regeneration procedure allows for many consecutive measurements without stripping off the membrane in between.

[1]  Günter Gauglitz,et al.  Kinetic analysis of the estrogen receptor alpha using RIfS , 2011, Analytical and bioanalytical chemistry.

[2]  Peter B Luppa,et al.  Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies. , 2007, Clinical chemistry.

[3]  T. Koike,et al.  Pathophysiology of thrombosis and potential targeted therapies in antiphospholipid syndrome. , 2011, Current vascular pharmacology.

[4]  M. S. Rasmussen,et al.  Synchronized Inhibition of the Phospholipid Mediated Autoactivation of Factor XII in Plasma by β2-glycoprotein I and Anti-β2-glycoprotein I , 1995, Thrombosis and Haemostasis.

[5]  J. Schölmerich,et al.  Das Antiphospholipidsyndrom Pathogenese, molekulare Grundlagen und klinische Aspekte , 2001, Medizinische Klinik.

[6]  P. Hogg,et al.  Anticardiolipin Antibodies Block the Inhibition by β2-Glycoprotein I of the Factor Xa Generating Activity of Platelets , 1993, Thrombosis and Haemostasis.

[7]  P. Meroni,et al.  Pathogenic role of anti-β2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of β2-glycoprotein I binding to trophoblast cells and functional effects of anti-β2-glycoprotein I antibodies in vitro , 2004, Annals of the rheumatic diseases.

[8]  M. Meurer.  Das Antiphospholipidsyndrom , 1994, Der Hautarzt.

[9]  C. Maas,et al.  Immune responses against domain I of β(2)-glycoprotein I are driven by conformational changes: domain I of β(2)-glycoprotein I harbors a cryptic immunogenic epitope. , 2011, Arthritis and rheumatism.

[10]  Chan Jun-mi,et al.  International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome(APS) , 2008 .

[11]  Andreas Brecht,et al.  An integrated system for optical biomolecular interaction analysis , 1997 .

[12]  G. Gauglitz,et al.  Characterisation of morphology of self-assembled PEG monolayers: a comparison of mixed and pure coatings optimised for biosensor applications , 2008, Analytical and bioanalytical chemistry.

[13]  Y. Shoenfeld,et al.  The involvement of beta2-glycoprotein I (beta2-GPI) in human and murine atherosclerosis. , 1999, Journal of autoimmunity.

[14]  G. Gauglitz,et al.  Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. , 2007, Endocrinology.

[15]  Günter Gauglitz,et al.  Reflectometric interference spectroscopy (RIfS) as a new tool to measure in the complex matrix milk at low analyte concentration , 2011, Analytical and Bioanalytical Chemistry.

[16]  P. D. de Groot,et al.  Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. , 2010, Blood.

[17]  G. Gauglitz,et al.  Surface modification for direct immunoprobes. , 1996, Biosensors & bioelectronics.

[18]  P. D. de Groot,et al.  Twenty-two Years of Failure to Set Up Undisputed Assays to Detect Patients with the Antiphospholipid Syndrome , 2008, Seminars in thrombosis and hemostasis.

[19]  Andreas Brecht,et al.  Interferometric measurements used in chemical and biochemical sensors , 1992 .

[20]  P. D. de Groot,et al.  Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I , 2010, Current rheumatology reports.

[21]  G Gauglitz,et al.  Label-free monitoring of DNA-ligand interactions. , 1997, Analytical biochemistry.

[22]  Günter Gauglitz,et al.  Direct optical detection in bioanalysis: an update , 2010, Analytical and bioanalytical chemistry.

[23]  M. L. Wagner,et al.  Tethered polymer-supported planar lipid bilayers for reconstitution of integral membrane proteins: silane-polyethyleneglycol-lipid as a cushion and covalent linker. , 2000, Biophysical journal.

[24]  P. Luppa,et al.  β2‐Glycoprotein I‐derived peptides as antigenic structures for the detection of antiphospholipid antibodies , 2010, Journal of thrombosis and haemostasis : JTH.

[25]  Michael Kumpf,et al.  Biosensor for Seven Sulphonamides in Drinking, Ground, and Surface Water with Difficult Matrices , 2004 .